Immunoglobulins in the treatment of COVID-19 infection: Proceed with caution!Clin Immunol. 2020 Jul; 216:108459.CI
Abstract
The COVID-19 pandemic is one of the greatest infectious challenges in recent history. Presently, few treatment options exist and the availability of effective vaccines is at least one year away. There is an urgent need to find currently available, effective therapies in the treatment of patients with COVID-19 infection. In this review, we compare and contrast the use of intravenous immunoglobulin and hyperimmune globulin in the treatment of COVID-19 infection.
Links
MeSH
Adaptive ImmunityAngiotensin-Converting Enzyme 2Antibody-Dependent EnhancementBetacoronavirusCOVID-19Coronavirus InfectionsCytokine Release SyndromeGene ExpressionHumansImmunity, InnateImmunization, PassiveImmunoglobulins, IntravenousImmunologic FactorsMolecular Targeted TherapyPandemicsPeptidyl-Dipeptidase APneumonia, ViralSARS-CoV-2Spike Glycoprotein, CoronavirusT-LymphocytesCOVID-19 Serotherapy
Pub Type(s)
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Review
Language
eng
PubMed ID
32418917
Citation
Nguyen, Alan A., et al. "Immunoglobulins in the Treatment of COVID-19 Infection: Proceed With Caution!" Clinical Immunology (Orlando, Fla.), vol. 216, 2020, p. 108459.
Nguyen AA, Habiballah SB, Platt CD, et al. Immunoglobulins in the treatment of COVID-19 infection: Proceed with caution! Clin Immunol. 2020;216:108459.
Nguyen, A. A., Habiballah, S. B., Platt, C. D., Geha, R. S., Chou, J. S., & McDonald, D. R. (2020). Immunoglobulins in the treatment of COVID-19 infection: Proceed with caution! Clinical Immunology (Orlando, Fla.), 216, 108459. https://doi.org/10.1016/j.clim.2020.108459
Nguyen AA, et al. Immunoglobulins in the Treatment of COVID-19 Infection: Proceed With Caution. Clin Immunol. 2020;216:108459. PubMed PMID: 32418917.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Immunoglobulins in the treatment of COVID-19 infection: Proceed with caution!
AU - Nguyen,Alan A,
AU - Habiballah,Saddiq B,
AU - Platt,Craig D,
AU - Geha,Raif S,
AU - Chou,Janet S,
AU - McDonald,Douglas R,
Y1 - 2020/05/11/
PY - 2020/5/5/received
PY - 2020/5/5/accepted
PY - 2020/5/19/pubmed
PY - 2020/7/14/medline
PY - 2020/5/19/entrez
KW - COVID-19
KW - Coronavirus
KW - Hyperimmune globulin
KW - Intravenous immunoglobulin
KW - SARS-CoV-2
SP - 108459
EP - 108459
JF - Clinical immunology (Orlando, Fla.)
JO - Clin Immunol
VL - 216
N2 - The COVID-19 pandemic is one of the greatest infectious challenges in recent history. Presently, few treatment options exist and the availability of effective vaccines is at least one year away. There is an urgent need to find currently available, effective therapies in the treatment of patients with COVID-19 infection. In this review, we compare and contrast the use of intravenous immunoglobulin and hyperimmune globulin in the treatment of COVID-19 infection.
SN - 1521-7035
UR - https://www.unboundmedicine.com/medline/citation/32418917/Immunoglobulins_in_the_treatment_of_COVID_19_infection:_Proceed_with_caution
DB - PRIME
DP - Unbound Medicine
ER -